Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (351-360 of 663) with videos related to

Pageof 67
Sort By:
Blood|December 26, 2008
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune controlApril L Ferre, Peter W Hunt, J William Critchfield, et al.
AIDS (London, England)|January 21, 2015
Select host restriction factors are associated with HIV persistence during antiretroviral therapyMohamed Abdel-Mohsen, Charlene Wang, Matthew C Strain, et al.
Plos One|August 15, 2017
Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controlsThijs Booiman, Ferdinand W Wit, Arginell F Girigorie, et al.
AIDS (London, England)|September 11, 2010
Virologic and immunologic response to HAART, by age and regimen classKeri N Althoff, Amy C Justice, Stephen J Gange, et al.
Plos One|August 6, 2011
Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approachElvin H Geng, David V Glidden, Mwebesa Bosco Bwana, et al.
The Lancet. HIV|October 2, 2015
Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trialChad J Achenbach, Lambert Assoumou, Steven G Deeks, et al.
Cell|November 1, 2019
Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing PlatformEytan Herzig, Kaman Chan Kim, Thomas A Packard, et al.
The Journal of Infectious Diseases|January 25, 2002
CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapySteven G Deeks, Rebecca Hoh, Robert M Grant, et al.
Nature Communications|March 3, 2026
HIV-seq reveals gene expression differences between HIV-transcribing cells from viremic and suppressed people with HIVJulie Frouard, Sushama Telwatte, Xiaoyu Luo, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Increased mannosylation of extracellular vesicles in Long COVID plasma provides a potential therapeutic target for <i>Galanthus nivalis</i> agglutinin (GNA) affinity resinMiguel A Pesqueira Sanchez, Rosalia de Necochea Campion, Thomas Dalhuisen, et al.
Pageof 67

Showing results (351-360 of 663) with videos related to

Sort By:
Pageof 67
Blood|December 26, 2008
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune controlApril L Ferre, Peter W Hunt, J William Critchfield, et al.
AIDS (London, England)|January 21, 2015
Select host restriction factors are associated with HIV persistence during antiretroviral therapyMohamed Abdel-Mohsen, Charlene Wang, Matthew C Strain, et al.
Plos One|August 15, 2017
Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controlsThijs Booiman, Ferdinand W Wit, Arginell F Girigorie, et al.
AIDS (London, England)|September 11, 2010
Virologic and immunologic response to HAART, by age and regimen classKeri N Althoff, Amy C Justice, Stephen J Gange, et al.
Plos One|August 6, 2011
Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approachElvin H Geng, David V Glidden, Mwebesa Bosco Bwana, et al.
The Lancet. HIV|October 2, 2015
Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trialChad J Achenbach, Lambert Assoumou, Steven G Deeks, et al.
Cell|November 1, 2019
Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing PlatformEytan Herzig, Kaman Chan Kim, Thomas A Packard, et al.
The Journal of Infectious Diseases|January 25, 2002
CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapySteven G Deeks, Rebecca Hoh, Robert M Grant, et al.
Nature Communications|March 3, 2026
HIV-seq reveals gene expression differences between HIV-transcribing cells from viremic and suppressed people with HIVJulie Frouard, Sushama Telwatte, Xiaoyu Luo, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Increased mannosylation of extracellular vesicles in Long COVID plasma provides a potential therapeutic target for <i>Galanthus nivalis</i> agglutinin (GNA) affinity resinMiguel A Pesqueira Sanchez, Rosalia de Necochea Campion, Thomas Dalhuisen, et al.
Pageof 67